86.77
Revvity Inc (RVTY) 最新ニュース
Revvity CEO Acknowledges Challenges In Immunodiagnostics Business In China: Retail Terms Stock Drop An ‘Overreaction’ - MSN
Revvity Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Revvity, Inc. Hits Day Low at $82.86 Amid Price Pressure - Markets Mojo
Revvity Inc. $RVTY Position Trimmed by Asset Management One Co. Ltd. - MarketBeat
Barclays downgrades Revvity (RVTY) - MSN
Is Now The Time To Look At Buying Revvity, Inc. (NYSE:RVTY)? - 富途牛牛
Revvity declares $0.07 dividend - MSN
Revvity expects to report Q4 revenue of $772 million - MSN
What to expect from Revvity's next quarterly earnings report - MSN
Is Revvity Inc (RVTY) a Bargain After 7.6% Drop? GF Value Says U - GuruFocus
Revvity (RVTY) slides as investors weigh softer growth profile and fresh analyst caution ahead of upcoming events - Quiver Quantitative
Revvity Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Revvity Drops 10.0% Amid Sector-Wide Selling - AlphaStreet
Revvity (NYSE:RVTY) Trading Down 9.7%What's Next? - MarketBeat
Why Revvity’s Stock Is Sinking Again Today - TipRanks
RVTY Revvity Inc. delivers 7.4 percent Q4 2025 EPS beat, shares climb 4.95 percent on upbeat investor sentiment.AI Stock Signals - UBND thành phố Hải Phòng
Roubaix Capital, LLC's Revvity Inc(RVTY) Holding History - GuruFocus
RVTY (Revvity Inc.) posts Q4 2025 EPS beat but dips slightly as investors react to muted year over year revenue growth.AI Powered Stock Picks - Cổng thông tin điện tử tỉnh Tây Ninh
Insider Sell: Anita Gonzales Sells Shares of Revvity Inc (RVTY) - GuruFocus
Revvity (RVTY) VP Gonzales sells 80 shares under 10b5-1 trading plan - Stock Titan
Revvity Inc. stock (US76155R1086): Is life sciences growth strong enough to unlock new upside? - AD HOC NEWS
Installing Digital Tools at Calyxia With Revvity Signals: Accelerating the Transition from IP to Production - AZoM
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity Inc. stock (US76155R1086): Why does its life sciences focus matter more for U.S. investors n - AD HOC NEWS
Revvity Inc. stock (US76155R1086): Is its life sciences focus strong enough to drive steady investor - AD HOC NEWS
RVTY (NYSE: RVTY) proposes sale of 80 common shares in Form 144 notice - Stock Titan
A Look At Revvity (RVTY) Valuation As Mixed Recent Returns Contrast With Undervaluation Narrative - Yahoo Finance
Revvity, Inc. (RVTY) Stock Analysis: Navigating a 22.53% Upside Potential in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
KBC Group NV Grows Stock Holdings in Revvity Inc. $RVTY - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $3.46 Million Stock Position in Revvity Inc. $RVTY - MarketBeat
The Bull Case For Revvity (RVTY) Could Change Following Its New AI-Enabled Oncology Platform Push - simplywall.st
Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To Know - Yahoo Finance
Revvity (NYSE:RVTY) Downgraded by Wall Street Zen to "Hold" - MarketBeat
Revvity Inc at Barclays Global Healthcare Conference Transcript - GuruFocus
Revvity Showcases Integrated Cancer Research Solutions at AACR Annual Meeting 2026 - marketscreener.com
Assessing Revvity (RVTY) Valuation After Signals BioDesign Launch And Earnings Anticipation - Sahm
Revvity Inc (RVTY) Shares Fall 3.6% -- What GF Score of 79 Tells Investors - GuruFocus
Revvity, Inc.: - marketscreener.com
Revvity to Present at Upcoming Investor Conferences - Business Wire
Barclays Maintains Revvity(RVTY.US) With Hold Rating, Maintains Target Price $95 - Moomoo
Revvity (NYSE:RVTY) Lowered to Equal Weight Rating by Barclays - MarketBeat
RVTY Maintains Neutral Rating by Goldman Sachs -- Price Target L - GuruFocus
The Goldman Sachs Group Lowers Revvity (NYSE:RVTY) Price Target to $95.00 - MarketBeat
Barclays Downgrades Revvity(RVTY.US) to Hold Rating, Cuts Target Price to $95 - Moomoo
Barclays Downgrades Revvity to Equalweight From Overweight, Adjusts Price Target to $95 From $118 - marketscreener.com
大文字化:
|
ボリューム (24 時間):